Manufacturer record
Bethel Medipharma Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Bethel Medipharma Private Limited (West Bengal) was declared Not of Standard Quality in March 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CF-B1, Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin & Menthol Syrup (Cofcil-A) (exp Jul 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Terbutaline Sulphate, Ambroxol Hydrochloride & Menthol. Listed in the March 2024 alert.
Records by type
1 record linked to Bethel Medipharma Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin & Menthol Syrup (Cofcil-A) | Batch CF-B1Mfg Aug 2023 · Exp Jul 2025 | Assay of Terbutaline Sulphate, Ambroxol Hydrochloride & MentholAssay | CDL KolkataCDSCO lab | Mar 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.